Analyst Coverage

FirmAnalystPhoneE-Mail
Citi ResearchYigal D. Nochomovitz, Ph.D.212.816.1441 yigal.nochomovitz@citi.com
Cowen & CompanyBoris Peaker, Ph.D., CFA646.562.1377boris.peaker@cowen.com
J.P. MorganWhitney Ijem212.622.4668whitney.g.ijem@jpmchase.com
JMP SecuritiesMichael G. King212.906.3520mking@jmpsecurities.com
Ladenburg ThalmannMatt Kaplan212.891.5247mkaplan@ladenburg.com
MaximJason Kolbert212.895.3516Jkolbert@maximgrp.com
Morgan StanleyAndrew Berens212.761.3017Andrew.Berens@morganstanley.com
Raymond JamesReni Benjamin, PhD212.883.4615reni.benjamin@raymondjames.com
Stifel NicolausStephen Willey212.271.3620swilley@stifel.com
Keryx Biopharmaceuticals, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Keryx Biopharmaceuticals, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Keryx Biopharmaceuticals, Inc. or its management. Keryx Biopharmaceuticals, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.